Neurocrine Biosciences Inc (NBIX)
137.76
-1.21
(-0.87%)
USD |
NASDAQ |
Apr 25, 16:00
138.11
+0.35
(+0.25%)
Pre-Market: 08:50
Neurocrine Biosciences Cash from Investing (TTM): -467.10M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -467.10M |
| September 30, 2023 | -380.90M |
| June 30, 2023 | -344.90M |
| March 31, 2023 | -187.60M |
| December 31, 2022 | -177.10M |
| September 30, 2022 | -37.80M |
| June 30, 2022 | -102.70M |
| March 31, 2022 | -224.90M |
| December 31, 2021 | -130.20M |
| September 30, 2021 | -301.60M |
| June 30, 2021 | -150.20M |
| March 31, 2021 | 34.00M |
| December 31, 2020 | 4.10M |
| September 30, 2020 | -14.40M |
| June 30, 2020 | -125.20M |
| March 31, 2020 | -218.90M |
| December 31, 2019 | -211.10M |
| September 30, 2019 | -151.14M |
| June 30, 2019 | -110.64M |
| March 31, 2019 | -144.85M |
| December 31, 2018 | -242.90M |
| September 30, 2018 | -196.05M |
| June 30, 2018 | -186.35M |
| March 31, 2018 | -365.15M |
| December 31, 2017 | -251.25M |
| Date | Value |
|---|---|
| September 30, 2017 | -176.70M |
| June 30, 2017 | -98.11M |
| March 31, 2017 | 99.55M |
| December 31, 2016 | 112.96M |
| September 30, 2016 | 119.85M |
| June 30, 2016 | 28.79M |
| March 31, 2016 | -9.465M |
| December 31, 2015 | -195.81M |
| September 30, 2015 | -202.32M |
| June 30, 2015 | -151.24M |
| March 31, 2015 | -155.73M |
| December 31, 2014 | -105.37M |
| September 30, 2014 | -100.18M |
| June 30, 2014 | -104.70M |
| March 31, 2014 | -25.31M |
| December 31, 2013 | 5.34M |
| September 30, 2013 | 12.50M |
| June 30, 2013 | 24.46M |
| March 31, 2013 | -24.62M |
| December 31, 2012 | -34.76M |
| September 30, 2012 | -63.10M |
| June 30, 2012 | -55.89M |
| March 31, 2012 | -27.61M |
| December 31, 2011 | -3.532M |
| September 30, 2011 | -21.93M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-467.10M
Minimum
Dec 2023
34.00M
Maximum
Mar 2021
-173.59M
Average
-151.14M
Median
Sep 2019
Cash from Investing (TTM) Benchmarks
| Globus Medical Inc | 302.97M |
| Inspire Medical Systems Inc | -294.82M |
| AIM ImmunoTech Inc | -0.832M |
| Protalix BioTherapeutics Inc | -16.71M |
| Armata Pharmaceuticals Inc | -8.134M |